Illumina

Onsite Field Service Engineer 2

California Twp, Michigan, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, GenomicsIndustries

Requirements

Candidates must possess a Bachelor's degree in Electrical/Electronics Engineering, Mechanical Engineering, or a related field, with 2-5 years of relevant field service or technical support experience. The role requires the ability to work independently and collaboratively in a fast-paced, customer-focused environment, and a willingness to travel within the assigned territory as needed (over 50%).

Responsibilities

The Field Service Engineer will install, upgrade, repair, and maintain instrument systems at customer sites. Responsibilities include troubleshooting and repairing system problems, submitting service and bug reports promptly, entering work performed into the service database, maintaining accurate service spares inventory, and revising/reviewing SOPs. The role also involves demonstrating the ability to align optical systems.

Skills

Field Service
Technical Support
Instrument Installation
Instrument Repair
Instrument Maintenance
Troubleshooting
Optical Systems Alignment
Electrical Engineering
Mechanical Engineering
Customer Service

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI